14
Views
10
CrossRef citations to date
0
Altmetric
Article

The Myc 3′ Wnt-Responsive Element Suppresses Colonic Tumorigenesis

&
Pages 1659-1669 | Received 26 Jul 2013, Accepted 16 Feb 2014, Published online: 20 Mar 2023
 

Abstract

Mutations in components of the Wnt/β-catenin signaling pathway are commonly found in colorectal cancers, and these mutations cause aberrant expression of genes controlled by Wnt-responsive DNA elements (WREs). While the c-Myc proto-oncogene (Myc) is required for intestinal phenotypes associated with pathogenic Wnt/β-catenin signaling in vivo, the WREs that control Myc expression in this setting have yet to be fully described. Previously, we demonstrated that the Myc 3′ WRE was required for intestinal homeostasis and intestinal repair in response to damage. Here, we tested the role of the Myc 3′ WRE in intestinal tumorigenesis using two independent mouse models. In comparison to ApcMin/+ mice, ApcMin/+ Myc 3′ WRE−/− mice contained 25% fewer tumors in the small intestine. Deletion of the Myc 3′ WRE−/− in the ApcMin/+ background resulted in 4-fold more colonic tumors. In a model of colitis-associated colorectal cancer, the Myc 3′ WRE suppressed colonic tumorigenesis, most notably within the cecum. Using chromatin immunoprecipitation and transcript analysis of purified colonic crypts, we found that the Myc 3′ WRE is required for the transcriptional regulation of Myc expression in vivo. These results emphasize the critical role of the Myc 3′ WRE in maintaining homeostatic Myc expression.

SUPPLEMENTAL MATERIAL

Supplemental material for this article may be found at http://dx.doi.org/10.1128/MCB.00969-13.

ACKNOWLEDGMENTS

We thank members of the Yochum laboratory for helpful discussions and Kang Li in the Morphological and Molecular Pathology Core Research Laboratory (Penn State University College of Medicine) for his help with embedding tissue sections and preparing slides for immunohistochemistry.

This research was supported by National Institutes of Health grant R01DK080805 (G.S.Y.).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.